Back to Search Start Over

"Residual Osteocytic Lesion": Effect of Denosumab (AMG 162) Treatment on the Morphology and Immunophenotype of Giant-Cell Tumor.

Authors :
Riddle, Nicole D.
Jones, Krister
Staddon, Arthur P.
Brooks, John S.
Source :
JBJS Case Connector; 2013, Vol. 3 Issue 1, p1-4, 4p
Publication Year :
2013

Abstract

The article presents case studies of two patients with unusual morphologic and immunophenotypic changes observed in a giant-cell tumor (GCT) of bone after treating with denosumab (AMG 162). It discusses the application of positron emission tomography (PET)/computed tomography (CT). Information about denosumab, a monoclonal antibody, is provided.

Details

Language :
English
ISSN :
21603251
Volume :
3
Issue :
1
Database :
Complementary Index
Journal :
JBJS Case Connector
Publication Type :
Academic Journal
Accession number :
86636709
Full Text :
https://doi.org/10.2106/JBJS.CC.L.00161